REVBNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as REVBW
REVELATION BIOSCIENCES, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$3.29+2.80 (+577.76%)
Close on Oct 19, 2026
- Market cap
- $12.58M
- P/E (TTM)
- –
- Dividend yield
- –
Revelation Biosciences statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Market Cap | $13.09M | $166.30M |
| Enterprise Value | $1.60M | $88.19M |
| PB Ratio | 1.30 | 2.03 |
| P/TBV Ratio | 1.30 | 2.29 |
Income (trailing twelve months)
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Operating Income | -$11.27M | -$21.40M |
| Net Income | -$10.75M | -$22.46M |
| EBITDA | -$11.27M | -$16.91M |
Returns
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Return on Equity (ROE) | -154.8% | -53.2% |
| Return on Assets (ROA) | -120.2% | -40.9% |
| Return on Capital Employed (ROCE) | -106.1% | -38.1% |
Balance sheet
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $11.48M | $61.43M |
| Net Cash (Debt) | $11.48M | $15.35M |
| Net Cash Per Share | $2.88 | $0.66 |
| Equity (Book Value) | $10.07M | $49.09M |
| Book Value Per Share | $2.53 | $1.37 |
| Tangible Book Value | $10.07M | $23.52M |
| Working Capital | $9.80M | $76.81M |
Financial position
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Current Ratio | 6.21 | 3.34 |
| Quick Ratio | 6.11 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Operating Cash Flow | -$9.33M | -$12.35M |
Efficiency
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Profits Per Employee | -$1.34M | -$703.34K |
| Employee Count | 8 | 74 |
Dividends and yields
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Earnings Yield | -82.2% | -23.3% |
Shares
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Shares Outstanding | 3,983,420 | 58,127,000 |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 2,916,200 | 49,136,700 |
| Shares Held by Insiders | 26.8% | 11.6% |
| Shares Held by Institutions | 41.8% | 59.4% |
Scores
| Measure | Revelation Biosciences | Industry median |
|---|---|---|
| Altman Z-Score | -5.05 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Revelation Biosciences's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.